Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The transcriptional coactivator PPAR gamma coactivator 1 alpha (PGC-1alpha) is a key regulator of metabolic processes such as mitochondrial biogenesis and respiration in muscle and gluconeogenesis in liver. Reduced levels of PGC-1alpha in humans have been associated with type II diabetes. PGC-1alpha contains a negative regulatory domain that attenuates its transcriptional activity. This negative regulation is removed by phosphorylation of PGC-1alpha by p38 MAPK, an important kinase downstream of cytokine signaling in muscle and beta-adrenergic signaling in brown fat. We describe here the identification of p160 myb binding protein (p160MBP) as a repressor of PGC-1alpha. The binding and repression of PGC-1alpha by p160MBP is disrupted by p38 MAPK phosphorylation of PGC-1alpha. Adenoviral expression of p160MBP in myoblasts strongly reduces PGC-1alpha's ability to stimulate mitochondrial respiration and the expression of the genes of the electron transport system. This repression does not require removal of PGC-1alpha from chromatin, suggesting that p160MBP is or recruits a direct transcriptional suppressor. Overall, these data indicate that p160MBP is a powerful negative regulator of PGC-1alpha function and provide a molecular mechanism for the activation of PGC-1alpha by p38 MAPK. The discovery of p160MBP as a PGC-1alpha regulator has important implications for the understanding of energy balance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Phosphorylation of PGC-1α by p38 prevents interaction with p160 repressor [77, 78] and increases protein stability [34].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260 · cited 2×
“Nuclear extracts were prepared from C2C12 myoblasts using the Dignam protocol (Dignam et al. 1983).”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 3×
“PGC-1 activates mitochondrial biogenesis and respiration in both brown fat and skeletal muscle, and is induced in the cold in both tissues (Puigserver et al. 1998; Wu et al. 1999).”
BackgroundMethodA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 12×
“To study the effects of p160MBP and p67MBP on PGC-1 in a more native context, we cotransfected vectors expressing these proteins with PGC-1 and one of its transcription factor targets, PPAR .”
BackgroundInfluentialTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · cited 4×
“Importantly, expression of PGC-1 in skeletal muscle in vivo via a transgene triggers the conversion of type IIb muscle fibers to type IIa and type I fibers, as evidenced by mitochondrial biogenesis and expression of myofibrillar proteins characteristic of slow-twitch muscle (Lin et al. 2002; Handschin et al. 2003).”
BackgroundInfluentialSelf-citationAnti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 1×
“The p38 MAPK sites are highly conserved across species and are downstream of both cytokine and -adrenergic signaling cascades (Tracey et al. 1987; Cao et al. 2001).”
BackgroundPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076 · cited 1×
“…partner for PPAR (Puigserver et al. 1998), but interacts with and coactivates many transcription factors, such as nuclear respiratory factor 1 (NRF-1), myocyte-enhancing factor2C (MEF2C), and most members of the nuclear hormone receptor family (for review, see Puigserver and Spiegelman 2003).”
BackgroundSelf-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 2×
“Most recently, decreases in skeletal muscle PGC-1 have been associated with human type 2 diabetes and those at risk for the development of diabetes (Mootha et al. 2003; Patti et al. 2003).”
BackgroundControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 2×
“PGC-1 is induced in liver in response to fasting, and activates key genes of the fasting response, including the genes of the gluconeogenic pathway and -oxidation of fatty acids (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundSelf-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 1×
“PGC-1 is induced in liver in response to fasting, and activates key genes of the fasting response, including the genes of the gluconeogenic pathway and -oxidation of fatty acids (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundSelf-citation
Cited by
Items 101–200 of 308
Exercise-induced PGC-1α transcriptional factors in skeletal muscle
Jung, S., & Kim, K. (2014) · Integrative Medicine Research · doi:10.1016/j.imr.2014.09.004 · Cited by 76
Mitochondrial dysfunction in human pathologies
Monsalve, M. (2007) · Frontiers in Bioscience · doi:10.2741/2132 · Cited by 75
“Signaling pathways associated with these stimuli (p38 MAP kinase, beta-adrenergic/cAMP, nitric oxide, AMP kinase and Cacalmodulin kinase) activate PGC-1alpha and its downstream target genes by increasing PGC-1alpha expression or transactivation function (137-140).”
BackgroundRNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 88
“…Organization1062 PPARg coactivator 1a (PGC-1a), the RelA/p65 subunit of NF-kB, Prep1, and mCRY1 (Favier and Gonda, 1994; Tavner et al, 1998; Jones et al, 2002; Fan et al, 2004; Diaz et al, 2007; Owen et al, 2007; Hara et al, 2009), although the influence of MYBBP1A on transcription was variable.”
BackgroundThe effects of short-chain fatty acids on the cardiovascular system
Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J., & Folkerts, G. (2016) · PharmaNutrition · doi:10.1016/j.phanu.2016.02.001 · Cited by 81
Galizzi, G., & Carlo, M. D. (2022) · Biology · doi:10.3390/biology11060943 · Cited by 86
“In addition, p38 MAPK increases the activity of PGC-1α by direct phosphorylation at Thr-262, Ser-265, and Thr-268, leading to the inhibition of PGC-1α and its repressor p160MBP interaction [227,228].”
BackgroundMitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
Godoy, J. A., Ríos, J. A., Picón-Pagès, P., Herrera-Fernández, V., Swaby, B., Crepin, G., Vicente, R., Fernández‐Fernández, J. M., & Muñoz, F. J. (2021) · Biomolecules · doi:10.3390/biom11071012 · Cited by 76
Saleem, A., Carter, H. N., & Hood, D. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00270.2013 · Cited by 72
“p160, and leads to its stabilization (6).”
Bonen, A. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-008 · Cited by 70
“Thus, it would appear that the activation of p38 MAPK, such as that that occurs during exercise, plays crucial roles in the regulation of PGC-1a in the following manners: p38 MAPK phosphorylates, stabilizes, and activates PGC-1a; and, through the activation of ATF-2, p38 MAPK induces PGC-1a expression (Akimoto et al.…”
BackgroundMetabolic Reprogramming in Dietary Restriction
Anderson, R. M., & Weindruch, R. (2006) · Interdisciplinary Topics in Gerontology · doi:10.1159/000096554 · Cited by 67
Kupr, B., & Handschin, C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00325 · Cited by 68
“…manner: p160MBP inhibits the ability of PGC-1α to regulate mitochondrial gene expression in the absence of p38 MAPK-mediated phosphorylation (Fan et al., 2004) while RIP140 associates with and represses sumoylated Frontiers in Physiology | www.frontiersin.org 3 November 2015 | Volume 6 |…”
BackgroundMethodMYBBP1a is a Novel Repressor of NF-κB
Owen, H. R., Elser, M., Cheung, E. C. W., Gersbach, M., Kraus, W. L., & Hottiger, M. O. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.099 · Cited by 77
Mechanisms of calcium-induced mitochondrial biogenesis and GLUT4 synthesis
Wright, D. C. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-062 · Cited by 68
Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus
Masutani, H., Yoshihara, E., Masaki, S., Chen, Z., & Yodoi, J. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-36sr · Cited by 72
Oliveira, R. L. G. S., Ueno, M., de Souza, C. T., Pereira-da-Silva, M., Gasparetti, A. L., Bezzera, R. M. N., Alberici, L. C., Vercesi, A. E., Saad, M. J. A., & Velloso, L. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00103.2004 · Cited by 65
“In a recent study, Fan and co-workers (10) demonstrated that the inhibition of PGC-1 transcriptional activity by hyperexpression and recruitment of p160 Myb binding protein reduces mitochondrial respiration.”
BackgroundMAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
Roth, R. J., Le, A. M., Zhang, L., Kahn, M., Samuel, V. T., Shulman, G. I., & Bennett, A. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39054 · Cited by 65
Nahirny, A., Livne‐Bar, I., Guo, X., & Sivak, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083049 · Cited by 70
“This model can now be used to dissect p38 signaling to further isolate these responses through specific inhibition of downstream kinase targets, such as MK2 and MSK1/2, or transcriptional regulators like PGC-1a [45,65].”
MethodMargolis, L. M., & Pasiakos, S. M. (2013) · Advances in Nutrition · doi:10.3945/an.113.004572 · Cited by 72
Mori, S., Bernardi, R., Laurent, A., Resnati, M., Crippa, A., Gabrieli, A., Keough, R. A., Gonda, T. J., & Blasi, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039723 · Cited by 71
“MYBBP1A binds to and inhibits several transcription factors, such as the PPARc co-activator 1a (PGC-1a) [6].”
BackgroundQu, Z., Pang, X., Mei, Z., Li, Y., Zhang, Y., Huang, C., Liu, K., Yu, S., Wang, C., Sun, Z., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103145 · Cited by 62
“It has been shown that Mybbp1a mediates diverse biological processes by interacting with many transcription factors [17 – 19].”
BackgroundMénage-à-Trois 1 Is Critical for the Transcriptional Function of PPARγ Coactivator 1
Sano, M., Izumi, Y., Helenius, K., Asakura, M., Rossi, D. J., Xie, M., Taffet, G. E., Hu, L., Pautler, R. G., Wilson, C. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.003 · Cited by 72
Akimoto, T., Li, P., & Yan, Z. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2008 · Cited by 60
Kobayashi, M., Deguchi, Y., Nozaki, Y., & Higami, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116025 · Cited by 67
“MYBBP1a represses transcriptional activity of PGC-1α by direct interaction in skeletal muscle [87].”
BackgroundExercise-induced mitochondrial biogenesis in skeletal muscle
Hood, D. A., & Saleem, A. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.009 · Cited by 62
Modulation of PGC-1 Coactivator Pathways in Brown Fat Differentiation through LRP130
Cooper, M. P., Uldry, M., Kajimura, S., Arany, Z., & Spiegelman, B. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805431200 · Cited by 56
Handschin, C. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799891003641074 · Cited by 56
HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP
Lane, E. A., Choi, D. W., García-Haro, L., Levine, Z. G., Tedoldi, M., Walker, S., & Danial, N. N. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.019 · Cited by 64
“For PGC1 a interaction studies, the DNA mixture for transfection included the following expression vectors: 1.5 m g HCF-1, 1 m g PGC1 a (Fan et al., 2004), and 1.5 m g OGT WT or D554N.”
InfluentialFunctional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 60
“repressor p160 myb binding protein (p160 mbp) [53, 61, 62].”
Backgroundp160 Myb-Binding Protein Interacts with Prep1 and Inhibits Its Transcriptional Activity
Diaz, V. M., Mori, S., Longobardi, E., Menéndez, G., Ferrai, C., Keough, R. A., Bachi, A., & Blasi, F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01290-07 · Cited by 61
“Indeed, as p160-dependent inhibition of PGC1- affects energy metabolism, mitochondrial biogenesis, and respiration in muscles and gluconeogenesis in the liver (15, 41), the reduced availability of Prep1 in the livers and muscles of Prep1i/i mice affects the extent of PGC1- inhibition, affecting insulin sensitivity.”
InfluentialZhang, T., Ikejima, T., Li, L., Wu, R., Yuan, X., Zhao, J., Wang, Y., & Peng, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00753 · Cited by 54
Optimizing training adaptations by manipulating glycogen
Baar, K., & McGee, S. (2008) · European Journal of Sport Science · doi:10.1080/17461390801919094 · Cited by 51
“PGC-1a activity is controlled by association with a repressor protein termed p160myb, which can powerfully inhibit PGC function by blocking its association with transcription factors (Fan et al., 2004).”
BackgroundRepression of rRNA transcription by PARIS contributes to Parkinson's disease
Kang, H., & Shin, J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.003 · Cited by 55
Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential
Fonseka, O., Gare, S. R., Chen, X., Zhang, J., Alatawi, N. H. O., Ross, C., & Liu, W. (2025) · Cells · doi:10.3390/cells14050324 · Cited by 53
Targeting PGC-1α to control energy homeostasis
Wu, Z., & Boss, O. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1329 · Cited by 48
“This phosphorylation leads to the release of inhibitory factors that bind to PGC-1 α , such as p160 MBP [51] .”
BackgroundHuang, W., Bansode, R. R., Bal, N. C., Mehta, M., & Mehta, K. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m019687 · Cited by 48
Holloway, G. P., Perry, C. G. R., Thrush, A. B., Heigenhauser, G. J. F., Dyck, D. J., Bonen, A., & Spriet, L. L. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00726.2007 · Cited by 48
“These observations underscore the complexity of mechanisms that regulate protein expression, including the influence of phosphorylation on increasing PGC-1 mRNA stability (37) or activation (16, 25), the ability of other proteins to suppress PGC-1 activity (11), and the importance of nuclear import (48).”
BackgroundHanniman, E. A., Lambert, G., Inoue, Y., Gonzalez, F. J., & Sinal, C. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600303-jlr200 · Cited by 48
“For example, a negative regulatory motif that represses transcriptional activity has been identified in the PGC-1a protein ( 51 ).”
García‐Giménez, J. L., Gimeno, A., González‐Cabo, P., Dasí, F., Bolinches-Amorós, A., Mollá, B., Palau, F., & Pallardó, F. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020666 · Cited by 59
“At the moment some mechanisms have been clarified, and the activity of PGC-1a can be modulated by numerous post-translational events, including phosphorylation of the p38 MAPK [36,37] and AMP kinase (AMPK) [38], among others.”
BackgroundOriente, F., Fernández, L. C., Miele, C., Iovino, S., Mori, S., Diaz, V. M., Troncone, G., Cassese, A., Formisano, P., Blasi, F., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00117-08 · Cited by 52
Takezawa, S., Yokoyama, A., Okada, M., Fujiki, R., Iriyama, A., Yanagi, Y., Ito, H., Takada, I., Kishimoto, M., Miyajima, A., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601548 · Cited by 50
“…(Sin3A, p107, HDAC1/2, RbAp48 and RbAp46 (Luo et al, 1998)); transcription factor Myb-associated co-repressors (NCoR (Li and McDonnell, 2002), Mybbp1A (Tavner et al, 1998; Fan et al, 2004) and CDK9 (De Falco et al, 2000)); and NCoR/SMRT-associated proteins (HDAC3 (Guenther et al, 2000)).”
RetractedPGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism
Coppi, L., Ligorio, S., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136913 · Cited by 50
“When PGC1α is not phosphorylated, it can dock to promoters but does not positively modulate transcription of target genes because of p160MBP inhibition [36], thus clarifying previous observations made by Knutti et al.”
ResultResveratrol exerts pharmacological preconditioning by activating PGC-1α
Tan, L., Yu, J., & Guan, H.-S. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.06.031 · Cited by 45
Firmin, F. F., Oger, F., Gheeraert, C., Dubois‐Chevalier, J., Vercoutter‐Edouart, A., Alzaïd, F., Mazuy, C., Dehondt, H., Alexandre, J., Derudas, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14570-y · Cited by 51
Pan, X., Whitten, D. A., Wilkerson, C. G., & Pestka, J. J. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft270 · Cited by 45
Metabolic Respiration Induces AMPK- and Ire1p-Dependent Activation of the p38-Type HOG MAPK Pathway
Adhikari, H., & Cullen, P. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004734 · Cited by 47
“p38 also regulates respiration in muscles, and gluconeogenesis in liver, and when mis-regulated can lead to problems that range from diabetes [135–137] to tumor malignancy [138].”
BackgroundMitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy
Tan, K.-L., Lee, H.-C., Cheah, P.-S., & Ling, K.-H. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2022.12.003 · Cited by 44
Kalliora, C., & Drosatos, K. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000891 · Cited by 45
Cao, L., Li, Y. S., Smirnov, A., Voshtani, R., Wang, T., Shao, C., Candi, E., Melino, G., Shi, Y., & Fang, J. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01519-2 · Cited by 57
Brenna, A., Grimaldi, B., Filetici, P., & Ballario, P. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0142 · Cited by 45
“The WC-1 long version, which is a PCR fragment corresponding to aa residues 354–100 of WC-1, was cloned in pGex 2T in a BamHI AA there is a 45% reduction of NGF-1/WC-1–binding activity, in accord with previous observations (Fan et al., 2004) and partially in accord with others (Jiang et al., 2010).”
ResultG Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ)
Wang, S., Awad, K. S., Elinoff, J. M., Dougherty, E. J., Ferreyra, G. A., Wang, J. Y., Cai, R., Sun, J., Ptasinska, A., & Danner, R. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638924 · Cited by 49
“Phosphorylation disrupts PGC1 binding to its repressor, p160 Myb-binding protein (p160), freeing it to dock with PPAR (19, 53).”
BackgroundMethodPan, X., Whitten, D. A., Wu, M., Chan, C., Wilkerson, C. G., & Pestka, J. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.007 · Cited by 42
“…protein 1A (MYBBP1A), found to be rapidly dephosphorylated at 30 min, is known to interact with and activate several transcription factors such as c-JUN, while repressing others such as PPARγ co-activator 1α (PGC-1α), NFκB, and c-MYB (Fan et al., 2004; Owen et al., 2007; Yamauchi et al., 2008).”
Forcales, S. V., & Puri, P. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.07.005 · Cited by 48
Sánchez‐de‐Diego, C., Artigas, N., Pimenta-Lopes, C., Valer, J. A., Torrejón, B., Gama-Pérez, P., Villena, J. A., García-Rovés, P. M., Rosa, J. L., & Ventura, F. (2019) · iScience · doi:10.1016/j.isci.2019.04.015 · Cited by 46
“On the other hand, the inhibition of SIRT1 by sirtinol reduced the levels of Osx and Fgf23 in IDG-SW3 cultures.”
BackgroundInfluentialMetz, L., Sirvent, P., Py, G., Brun, J. ‐., Fédou, C., de Mauverger, É. R., & Mercier, J. G. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.015 · Cited by 44
“It is now well known that the activity of mitochondria is altered in type 2 diabetes [27], and recent research has highlighted the involvement of numerous genes [28] and, in particular, the importance of transcription factor and their coactivators in metabolic disturbances characteristic of insulin resistance and diab…”
BackgroundTargeting Mitochondrial Network Architecture in Down Syndrome and Aging
Mollo, N., Cicatiello, R., Aurilia, M., Scognamiglio, R., Genesio, R., Charalambous, M., Paladino, S., Conti, A. M. F., Nitsch, L., & Izzo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093134 · Cited by 41
“Furth rmore, PGC-1α is negatively regulated by p160MBP and by PARIS, a KRAB and zinc finger prot in that contributes to he neurodegeneration occurring in Parkinson dise se (PD) [75,76].”
BackgroundYamauchi, T., Keough, R. A., Gonda, T. J., & Ishii, S. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01148.x · Cited by 44
Molecular characterization of Mybbp1a as a co-repressor on the Period2 promoter
Hara, Y., Onishi, Y., Oishi, K., Miyazaki, K., Fukamizu, A., & Ishida, N. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn1013 · Cited by 41
“In addition, Mybbp1a is a negative regulator of PGC- 1a, which is a transcription coactivator that regulates energy metabolism ( 23 ).”
BackgroundInfluentialInhibition of H3K18 deacetylation of Sirt7 by Myb-binding protein 1a (Mybbp1a)
Karim, M. F., Yoshizawa, T., Sato, Y., Sawa, T., Tomizawa, K., Akaike, T., & Yamagata, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.020 · Cited by 37
PGC-1α, un co-activateur transcriptionnel impliqué dans le métabolisme
Tiraby, C., & Langin, D. (2005) · médecine/sciences · doi:10.1051/medsci/200521149 · Cited by 52
“Ce domaine contient un motif LXXLL (L3) qui se lie à une ou plusieurs protéines répresseurs [15, 18].”
BackgroundMyb-binding Protein 1a (Mybbp1a) Regulates Levels and Processing of Pre-ribosomal RNA
Hochstatter, J., Hölzel, M., Michaela, R., Schermelleh, L., Leonhardt, H., Keough, R. A., Gonda, T. J., Imhof, A., Eick, D., Längst, G., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303719 · Cited by 43
Hallenborg, P., Fjære, E., Liaset, B., Petersen, R. K., Murano, I., Sonne, S. B., Falkerslev, M., Winther, S., Jensen, B. A. H., Ma, T., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00119.2015 · Cited by 42
Zc3h10 is a novel mitochondrial regulator
Audano, M., Pedretti, S., Cermenati, G., Brioschi, E., Diaferia, G. R., Ghisletti, S., Cuomo, A., Bonaldi, T., Salerno, F., Mora, M., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745531 · Cited by 37
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.043 · Cited by 41
“Activation of this kinase is known to increase both the expression and activity of PGC-1a [20,24,25].”
BackgroundFelder, T. K., Soyal, S. M., Oberkofler, H., Hahne, P., Auer, S., Weiss, R., Gadermaier, G., Miller, K. N., Krempler, F., Esterbauer, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227496 · Cited by 38
The kinase p38 Regulates Peroxisome Proliferator Activated Receptor-γ in Human Trophoblasts
Schild, R. L., Sonnenberg-Hirche, C., Schaiff, W. T., Bildirici, İ., Nelson, D. M., & Sadovsky, Y. (2005) · Placenta · doi:10.1016/j.placenta.2005.01.012 · Cited by 40
“Other proteins that directly or indirectly interact with PPARg are targetfor p38phosphorylation,includingthe hetero-partner of PPARg, RXR, the PGC-1 repressor p160myb binding protein (p160MBP), and C/EBPb [48,58, 59 ].”
BackgroundEpigeneitc silencing of ribosomal RNA genes by Mybbp1a
Tan, B. C., Yang, C., Hsieh, C.-L., Chou, Y.-H., Zhong, C. Z., Yung, B. Y., & Liu, H. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-57 · Cited by 36
“Mybbp1a has also been shown to interact with a number of other transcription factors, including PGC-1α, RelA/p65, Prep1, Aire, and CRY1, and exert inhibitory effect on their transactivation activity [4-9].”
BackgroundLarade, K., & Storey, K. B. (2005) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2005.10.008 · Cited by 33
“IthasbeendemonstratedbyEngelmanetal.(1998)thatinduction of PPAR-g is impaired in the presence of p38 inhibitors, whereas various cytokines have beenshown to activate the transcriptional PPAR gamma coactivator-1 (PGC-1) through phosphorylation by p38 MAPK ( Fan et al., 2004 ).”
BackgroundThe Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
Felipe‐Abrio, B., & Carnero, A. (2020) · Cancers · doi:10.3390/cancers12010254 · Cited by 37
“Directly, it has been published that MYBBP1A binds to PGC-1α, negatively regulating its activity as a transcriptional coactivator [20].”
BackgroundInfluentialWall, J. A., Wei, J., Ly, M., Belmont, P. J., Martindale, J. J., Tran, D. H., Sun, J., Chen, W. J., Yu, W., Oeller, P. W., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01311.2005 · Cited by 35
“For example, p38 can phosphorylate PGC-1 , as well as p160 myb binding protein, a PGC-1 suppressor; these phosphorylation events increase PGC-1 mediated coactivation of PPAR- -dependent gene induction, which leads to increased levels of oxidative phosphorylation proteins (3, 12).”
BackgroundIrisin and myostatin responses to acute high-intensity interval exercise in humans
Kabak, B., Belviranlı, M., & Okudan, N. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0008 · Cited by 35
Pattabiraman, D. R., Sun, J. Q. J., Dowhan, D. H., Ishii, S., & Gonda, T. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0070 · Cited by 31
“The Mybbinding protein, Mybbp1a (24), also interacts with the HLR and has been reported to act as a corepressor of PGC-1α (42) and Prep1 (43) as well as a coactivator of the dioxin receptor (44).”
BackgroundInteractome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF)
Zhao, J., Yu, H., Lin, L., Tu, J., Cai, L., Chen, Y., Zhong, F., Lin, C., He, F., & Yang, P. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.08.021 · Cited by 32
“[73] Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin JD, et al.”
BackgroundMYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis
Akaogi, K., Ono, W., Hayashi, Y., Kishimoto, H., & Yanagisawa, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-65 · Cited by 40
“Prep1 is involved in development and organogenesis, and PGC-1α is a key regulator of metabolic processes such as mitochondrial biogenesis, respiration, and gluco neogenesis in the liver [32,33].”
BackgroundWeng, X., Wu, J., Lv, Z., Peng, C., Chen, J., Zhang, C., He, B., Tong, R., Hu, W., Ding, C., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.029 · Cited by 33
Rohrbach, S., Aslam, M., Niemann, B., & Schulz, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12650 · Cited by 38
“Insulin has been demonstrated to inhibit the p38 MAPK-mediated increase in PGC-1α expression (Hong et al., 2011) and prolonged exposure to insulin decreases mitochondrial mass, cellular ATP content, and oxygen consumption in hepatocytes (Liu et al., 2009).”
BackgroundInfluentialSeebacher, F., Schwartz, T. S., & Thompson, M. B. (2005) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2005.3333 · Cited by 35
Ethanol Suppresses PGC-1α Expression by Interfering with the cAMP-CREB Pathway in Neuronal Cells
Liu, Z., Liu, Y., Gao, R., Li, H., Dunn, T. J., Wu, P., Smith, R. G., Sarkar, P. S., & Fang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104247 · Cited by 38
“, CaMK, calcineurin A, PKC, and cAMP-CREB pathways [42–45].”
Nuclear receptor coregulators: their modification codes and regulatory mechanism by translocation
Baek, S. H., & Rosenfeld, M. G. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.169 · Cited by 39
Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γAgonist against MPTP
Swanson, C. R., Du, E. Y., Johnson, D. A., Johnson, J. A., & Emborg, M. E. (2013) · PPAR Research · doi:10.1155/2013/582809 · Cited by 31
McKie, G. L., & Wright, D. C. (2020) · Biochemical Journal · doi:10.1042/bcj20190466 · Cited by 32
Pknox1/Prep1 Regulates Mitochondrial Oxidative Phosphorylation Components in Skeletal Muscle
Kanzleiter, T., Rath, M., Penkov, D., Puchkov, D., Schulz, N., Blasi, F., & Schürmann, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01232-13 · Cited by 30
“The activity of PGC-1 depends on the stability of p160 Mybp1 (p160 c-myb binding protein 1; p160), which is a known inhibitor of PGC-1 (15).”
BackgroundTranscriptional Control of the Pgc-1α Gene in Skeletal Muscle In Vivo
Yan, Z., Li, P., & Akimoto, T. (2007) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3180a03169 · Cited by 29
Regulation of PPARγCoactivator-1αFunction and Expression in Muscle: Effect of Exercise
Uguccioni, G., D'souza, D., & Hood, D. A. (2010) · PPAR Research · doi:10.1155/2010/937123 · Cited by 28
“The p38-mediated phosphorylation of PGC-1α disrupts the binding of p160MBP to the coactivator, allowing for its activation [42].”
BackgroundBrenmoehl, J., Walz, C., Caffier, C., Brosig, E., Walz, M., Ohde, D., Trakooljul, N., Langhammer, M., Ponsuksili, S., Wimmers, K., et al. (2021) · Cells · doi:10.3390/cells10123418 · Cited by 28
Identification of Myb-binding Protein 1A (MYBBP1A) as a Novel Substrate for Aurora B Kinase
Perrera, C., Colombo, R., Valsasina, B., Carpinelli, P., Troiani, S., Modugno, M., Gianellini, L. M., Cappella, P., Isacchi, A., Moll, J. K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068312 · Cited by 33
Puurand, M., Peet, N., Piirsoo, A., Peetsalu, M., Soplepmann, J., Sirotkina, M., Peetsalu, A., Hemminki, A., & Seppet, E. K. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1399-3 · Cited by 27
“Activated p38 stimulates the transcriptional coactivator of PPARc coactivator 1a (PGC-1a) through hindering binding of p160, a repressor of the transcription of PGC-1a target genes, to PGC-1a [33].”
BackgroundAcute exercise induces biphasic increase in respiratory mRNA in skeletal muscle
Ikeda, S., Kizaki, T., Haga, S., Ohno, H., & Takemasa, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.095 · Cited by 28
“becomes able to bind transcriptional factors such as NRF-1 and initiate transcriptional activity [36, 37 ].”
BackgroundSong, P., Zhao, J., Li, F., Zhao, X., Feng, J., Su, Y., Wang, B., & Zhao, J. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00968-4 · Cited by 28
“In addition, the PGC-1α transcriptional activity can be modulated by p38 mitogen-activated protein kinase, a post-translational modification pathway [26–28].”
BackgroundStem cells, phenotypic inversion, and differentiation.
Siggins, R. W., Zhang, P., Welsh, D. A., LeCapitaine, N. J., & Nelson, S. (2008) · PubMed Central · Cited by 25
Holloway, G. P. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-028 · Cited by 25
Oral quercetin administration transiently protects respiratory function in dystrophin‐deficient mice
Selsby, J. T., Ballmann, C. G., Spaulding, H. R., Ross, J. W., & Quindry, J. C. (2016) · The Journal of Physiology · doi:10.1113/jp272057 · Cited by 27
“The PGC-1α pathway is also regulated by p38 MAPK via phosphorylation (Fan et al. 2004; Pogozelski et al. 2009).”
BackgroundWatkins, J., Basu, S., & Bogenhagen, D. F. (2007) · Journal of Proteome Research · doi:10.1021/pr070300g · Cited by 27
The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer
Minervini, G., Pennuto, M., & Tosatto, S. C. E. (2020) · Open Biology · doi:10.1098/rsob.200109 · Cited by 27
Soriano, F. X., Léveillé, F., Papadia, S., Bell, K. F. S., Puddifoot, C. A., & Hardingham, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3568 · Cited by 27
Yubero, P., Hondares, E., Carmona, M. C., Rosell, M., Gonzalez, F. J., Iglesias, R., Giralt, M., & Villarroya, F. (2004) · Endocrinology · doi:10.1210/en.2004-0099 · Cited by 28
Lai, Y., Qiao, M., Song, M., Weintraub, S. T., & Shiio, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016975 · Cited by 25
“. More recently p160 was shown to bind and inhibit the coactivator PGC-1α”
BackgroundBhlhe40 Represses PGC-1α Activity on Metabolic Gene Promoters in Myogenic Cells
Chung, S. Y., Kao, C. H., Villarroya, F., Chang, H. Y., Chang, H. C., Hsiao, S. P., Liou, G., & Chen, S. L. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00387-15 · Cited by 22
“These stable clones carry a bidirectional tetracycline response element (TRE) driving the tetracycline-repressible (TET-off) expression of both VP16 –Bhlhe40-(1-135) and EGFP.”
BackgroundMethodInfluentialEpigenetic silencing of myogenic gene program by Myb‐binding protein 1a suppresses myogenesis
Yang, C., Liu, H., Chen, S. L., Wang, T., Hsieh, C., Huang, Y., Chen, S.-J., Chen, H., Yung, B. Y., & Tan, B. C. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.24 · Cited by 22
“Towards this end, we first performed a co-immunoprecipitation assay and showed that there was a co-precipitation of HDAC1 and HDAC2 with the exogenous (Myc–Mybbp1a) or endogenous Mybbp1a (Figure 4A).”
InfluentialOsman, A. M., Pennings, J. L. A., Blokland, M., Peijnenburg, A., & Loveren, H. V. (2009) · Journal of Immunotoxicology · doi:10.3109/15476910903496691 · Cited by 26
“, 1998)], acts as a repressor of several transcription factors and activator for others (Jones et al., 2002; Fan et al., 2004; Owen et al., 2007).”
BackgroundInfluentialOdeh, M., Tamir, Y., Haas, T., & Bengal, E. (2019) · FEBS Journal · doi:10.1111/febs.15070 · Cited by 22
Zc3h10 Acts as a Transcription Factor and Is Phosphorylated to Activate the Thermogenic Program
Yi, D., Dempersmier, J. M., Nguyen, H. P., Viscarra, J. A., Dinh, J., Nakamura-Tabuchi, C., Wang, Y., & Sul, H. S. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.099 · Cited by 26
“Furthermore, although p38 MAPK enhances PGC1α stability and transcription (Knutti et al., 2001; Puigserver et al., 2001), phosphorylation has also been reported to remove the binding and repression by p160 Myb binding protein (Fan et al., 2004), resulting in increased PGC1a transcriptional capacity.”
Background
Metadata
- Authors
- Fan, M., Rhee, J., St-Pierre, J., Handschin, C., Puigserver, P., Lin, J., Jäeger, S., Erdjument-Bromage, H., Tempst, P., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-01-26
- Volume
- 18
- Issue
- 3
- Pages
- 278-289
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC338281
- OpenAlex
- W6931824552
- Cited by
- 309
- References
- 30
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 10 · 2016: 8 · 2015: 13 · 2014: 10 · 2013: 19 · 2012: 18
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- edoc (University of Basel)
- Funders
- National Institutes of Health (DK54477, CA08748)
- National Eye Institute (5T32EY07110, T32EY007110)
- National Cancer Institute (P30-CA-08748, CA08748, P30CA008748)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54477, R56DK054477, R01DK054477)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mitochondrial respiration, PGC-1α, p38 MAPK, transcriptional coactivator, mitochondrial biogenesis, oxidative phosphorylation
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, DNA-Binding Proteins, Energy Metabolism, Gene Expression Regulation, Mitochondria, Muscle, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Transfection, RNA-Binding Proteins, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Cell Respiration, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Nucleocytoplasmic Transport Proteins, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.